Abstract. Previously, a high affinity, glycosylphosphatidylinositol-anchored receptor for folate and a caveolae internalization cycle have been found necessary for potocytosis of 5-methyltetrahydrofolate in MA104. We now show by cell fractionation that folate receptors also must be clustered in caveolae for potocytosis. An enriched fraction of caveolae from control cells retained 65-70% of the [3H]folic acid bound to cells in culture. Exposure of cells to the cholesterol-binding drug, filipin, which is known to uncluster receptors, shifted ~50% of the bound [3H]folic acid from the caveolae fraction to the noncaveolae membrane fraction and markedly inhibited internalization of [3H]folic acid. An mAb directed against the folate receptor also shifted ~50% of the caveolae-associated [3H]folic acid to noncaveolae membrane, indicating the antibody perturbs the normal receptor distribution. Concordantly, the mAb inhibited the delivery of 5-methyl[3H]tetrahydrofolate to the cytoplasm. Receptor bound 5-methyl[3H]tetrahydrofolate moved directly from caveolae to the cytoplasm and was not blocked by phenylarsine oxide, an inhibitor of receptor-mediated endocytosis. These results suggest cell fractionation can be used to study the uptake of molecules by caveolae.
T
HERE is now considerable evidence that the receptor-mediated delivery of 5-methyltetrahydrofolate to the cell cytoplasm occurs by a unique endocytic pathway called potocytosis (4) . First, the folate receptor is anchored by glycosylphosphatidylinositol (GPI) 1 rather than a transmembrane domain and localizes to caveolae instead of clathrin-coated pits (24) . Second, transfer of membrane-bound 5-methyltetrahydrofolate to the cytoplasm appears to occur from a compartment that is associated with the plasma membrane rather than from an internal, endosomal compartment (11) (12) (13) . Third, the kinetics of folate receptor recycling are distinctly different from those receptors that recycle using clathrin-coated pits (11) . Fourth, inhibition of caveolae internalization either by depleting membrane cholesterol (6) , treatment with PMA (29) , or exposure to histamine (31) specifically blocks 5-methyltetrahydrofolate uptake. Finally, chimeric folate receptors that contain a coated pit targeting sequence deliver folate to the cytoplasm less efficiently than normal receptors and, in addition, lack the ability to regulate folate accumulation (22) .
Several aspects of the potocytosis pathway remain unclear because there is not a ligand suitable for visualizing the internalization step with the electron microscope. Without this tool, investigators must rely on immunocytochemistry for information about the distribution of folate receptors (18, 24) . After the application of primary and secondary antibodies, the folate receptor is clearly associated with caveolae. There is disagreement about whether the antibodies induce the migration of these molecules into caveolae (18) or, instead, detect their native distribution (24) . Without an EM marker, it is also not possible to determine the mechanism of sequestration. Do caveolae actually bud from the membrane and form a vesicle that migrates to other compartments in the cell or do they remain associated with the plasma membrane and close transiently during internalization?
Another way to obtain basic information about the caveolae membrane traffic pattern, and potocytosis in general, is to use cell fractionation. This approach has provided critical information about membrane recycling during receptor-mediated endocytosis (1) . Initially, caveolae were isolated from tissue-culture cells by taking advantage of the Triton X-100 insolubility of this membrane (26) . While this method continues to be a valuable tool (16, 31) , Triton X-100 can remove resident proteins from caveolae (7) . A new purification scheme circumvents the use of detergents (32) and has the added advantage that one can follow bound ligands (32) and enzyme activities (28) associated with this membrane. We have now used this method to study the internalization process. The resuits suggest that ~70% of folate receptors are naturally clustered on the cell surface. Incubation of cells in the presence of mAb anti-folate receptor IgG stimulates unclustering of half of these receptors and inhibits the delivery of 5-methyltetrahydrofolate to the cytoplasm. In addition, open caveolae (external folate receptors) and closed caveolae (internal receptors) are always in the same caveolae fraction isolated from the plasma membrane. Cell fractionation promises to be a valuable tool for studying potocytosis in many different cells and tissues.
Materials and Methods

Materials
Medium 199 with Earle's salts minus folic acid was prepared by standard methods. FCS was from Hazleton Research Products, Inc. (Lenexa, KS). Glutamine, trypsin-EDTA, and penicillin/streptomycin were from GIBCO BRL (Gaithersburg, MD 
Methods
Cell Culture. The monkey kidney epithelial cell line, MA104, was grown as a monolayer in folate-free medium 199 supplemented with 5% (vol/vol) FCS and 100 U/ml penicillin/streptomycin. Cells for each experiment were set up according to a standard format. On day 0, cells were seeded into T-25 (1.5 × 105 cells) or T-75 (3 x 105 cells) culture flasks and cultured for 5 d without further feeding. For folate-binding studies, the medium was replaced with folate-free M199 containing 20 mM Hepes (pH 7.4) without serum, and additions were made directly to the culture flasks.
Purification of Caveolae. The caveolae isolation procedure was a modification of the method developed by Smart et al. (32) . All steps were carried out at 4°C. Purified plasma membranes were prepared from 10 100-mm dishes or T-75 flasks of confluent tissue-culture cells (8-10 mg of total protein) by Percoll gradient centrifugation. Each dish/flask was washed twice with 5 ml of buffer A, and the cells were collected by scraping in 3 ml of buffer A. The cells were pelleted by centrifugation for 5 min at 1,400 g in an IEC Centra-4B centrifuge (International Equipment Co., Needham Heights, MA). The cells were resuspended in 1.0 ml of buffer A, placed in a 2-ml tissue grinder (No. 0841416A; Wheaton Instruments, Millville, N J), and homogenized with 20 strokes of the teflon homogenizer. We transferred the suspension to a 1.5-ml centrifuge tube and centrifuged at 1,000 g for 10 min in an Eppendorf 5415C centrifuge (Eppendorf North American, Inc., Madison, WI). The postnuclear supernatant fraction (PNS) was removed and stored on ice. The pellet from each tube was resuspended in 1.0 ml of buffer A, homogenized, and centrifuged at 1,000 g for 10 min again. The two post nuclear supernatant fractions were combined (~4 mg of total protein), layered on the top of 23 ml of 30% Percoll in buffer A, and centrifuged at 84,000 g for 30 min in a rotor (Ti 60; Beckman Instruments, Inc., Palo Alto, CA). The plasma membrane fraction was a visible band ~5.7 cm from the bottom of the centrifuge bottle. The membrane fraction, which contained ~0.6 mg of protein, was collected with a Pasteur pipette, adjusted to 2.0 ml with buffer A, and placed in a centrifuge tube (TH641; Sorvall Instruments Division, DuPont Co., Newton, CT) on ice. We placed a 3-mm-diam sonication probe equidistant from the bottom of the tube and the top of the solution and sonicated the sample six successive times (total power of 50 1 each time), using the automatic settings of a Vibra Cell sonicator (model VC60S; Sonics & Materials Inc., Danbury, CT.). An aliquot of the sonicate was saved before mixing the remainder with 1.84 mt of buffer C and 0.16 ml of buffer A (final OptiPrep concentration, 23%) in the bottom of the same TH641 tube. A linear 20-10% OptiPrep gradient (6 ml) (prepared by diluting buffer C with buffer A) was poured on top of the sample, and then centrifuged at 52,000 g, for 90 min in a Sorvall TH641 swinging bucket rotor. The top 5 ml of the gradient (fractions 1 to 7) was collected, placed in a fresh TH641 centrifuge tube, and mixed with 4 ml of buffer C. The sample was overlaid with 1 ml of 15% OptiPrep and 0.5 ml of 5% OptiPrep (prepared by diluting buffer C with buffer A) and centrifuged at 52,000 g for 90 rain at 4°C. A distinct opaque band was present at both interfaces. The band at the 5 % interface was collected and designated caveolar membranes. Typically, we obtained 10-20 Ixg of protein in this band.
Folate Receptor Sequestration. A standard [3H]folic acid binding assay was used to measure internal and external folate receptors (10) . After the indicated treatments, MA104 cells were incubated in the presence of 5 nM [3H]folic acid for 1 h at 37°C. External [3H]folic acid corresponded to the amount released when ceUs were incubated on ice for 30 s in the presence of acid saline (0.15 M NaCI, adjusted to pH 3.0 with glacial acetic acid). Internal folate was the amount of [3H]folic acid that remained associated with the acid saline-treated cells. The latter was collected by adding 0.1 N NaOH to the flask to dissolve the cells. Radioactivity was measured by liquid scintillation counting using a liquid scintillation analyzer (Tri-carb 1900A; Packard Instrument Co., Inc., Downers Grove, IL). Nonspecific binding, which was measured by adding 100-fold excess unlabeled folic acid, was <5% of specific binding.
Transferrin Uptake. MAI04 cells were washed once with PBS before 1.5 ml of Ml99 medium containing 20 mM Hepes (pH 7.4) was added to each flask. Cells were preincubated in the presence or absence of PMA (1 txM) or phenylarsine oxide (20 tzM) for 30 min at 4°C. 125I-transferrin (0.32 ~g/ml, sp act 0.25 p.Ci/ml) was added to each dish, and the cells were incubated at 37°C for the indicated time. The flasks were chilled on ice for 20 min, and 1.5 ml of lysis buffer (10 mM Tris, pH 8.0, containing 1 IxM unlabeled transferrin) was added to each flask. The cells were placed at -80°C for 15 min and thawed on ice. The suspension was collected, and the flask was washed with 1.0 ml of lysis buffer at 4°C. The two were combined and centrifuged for 20 rain at 100,000 g to separate the membrane (pellet) from the cytosol (supernatant). The radioactivity in each was measured in a gamma counter. Nonspecific binding of 1251-transferrin was <20%,
To measure the migration of transferrin to internal membrane compartments, cells were incubated in the presence of ~2sI-transferrin as described above before preparing a postnuclear fraction and separating cytosol, plasma membrane, and internal membranes on Percoll gradients. The cytosol fraction corresponded to the top 2 ml of the gradient, while the plasma membrane fraction was the visible band in fraction 4. The remaining fractions, which contained the intracellular membranes, were pooled and centrifuged at 185,000g for 1.5 h at 4°C to obtain a pellet.
ElectrophoresisandImmunoblots. Protein concentrations were determined by the Bradford assay (Bio Rad Laboratories, Richmond, CA). Proteins were concentrated by TCA precipitation, washed in acetone, and resuspended in distilled water before the addition of 5x Laemmli sample buffer and heating at 95°C for 2 rain. Protein samples were loaded onto 12.5 % SDS polyacrylamide gels and separated by the method of Laemmli (15) before transferring to polyvinylidene ditluoride membranes. The membrane was blocked in TBST (20 mM Tris, pH 7.6, 137 mM NaC1. 0.5% Tween-20) plus 5% dry milk for 1 h at room temperature. Primary antibodies were diluted in TBST + 1% dry milk and added to the incubation mixture for 1 h at room temperature. After the primary antibody incubation, the membrane was washed four times, 10 rain each in TBST + 1% dry milk. The appropriate secondary antibody conjugated to HRP was diluted 1:30,000 and added to the incubation mixture for 1 h at room temperature. The membrane was then washed and processed to visualize reactive proteins by the chemiluminescence method.
Quantification. For the folate receptor sequestration, 5-methyltetrahydrofotate uptake and transferrin uptake experiments, ligand binding was determined either by liquid scintillation or a gamma radiation counting. Each time point had three to six independent determinations per experiment. In addition, each experiment was conducted at least three times. Although the absolute numbers varied between experiments, the results were always the same. Representative experiments are shown. For the quantification of radiation in the different OptiPrep 1 gradients, 50 jxl from each fraction was measured. Each fractionation experiment was conducted at least four times with similar results.
Results
A membrane receptor is said to be clustered when mor-
The Journal of Ceil Biology, Volume 134, 1996phologic methods detect multiple receptors in a restricted area of the cell surface (3). The isolated region of membrane also contains a high concentration of the receptor relative to the remainder of the plasma membrane (19) . Previously, we used immunoblotting to show that the caveolae fraction isolated from MA104 cells is enriched in folate receptors (32) . A more quantitative method for assessing enrichment is to measure the amount of receptorbound [3H]folic acid in the caveolae fraction. Folic acid binds with such a high affinity that it cannot dissociate from the receptor and move to the cytoplasm of the cell after internalization (11) . Folate-depleted MA104 cells were incubated in the presence of 5 nM [3H]folic acid for 1 h at 37°C to label both internal and external folate receptors. Isolated plasma membranes, which contained all of the cell-associated [3H]folic acid, were sonicated and separated on the first of the two OptiPrep gradients used to purify caveolae (Fig. 1 A) (23) . Therefore, we identified a concentration of filipin that was not toxic to cells, as judged by trypan blue exclusion. We incubated cells in the presence of filipin for 15 min before adding [3H]folic acid to the dish and further incubating 1 h at 37°C. Filipin had no effect on total [3H]folic acid binding, indicating the receptors were not inactivated by the drug (compare PM in Table I with   Table II ). By contrast, we observed a >50% loss of bound [3H]folic acid from the caveolae fraction and a reciprocal increase of [3H]folic acid in the noncaveolae fraction (compare Table I with Table II ). Filipin did not affect the amount of protein recovered in each fraction. Immunoblotting also detected an altered distribution of folate receptors in filipin-treated cells (Fig. 3) . This was best seen in immunoblots of the fractions from the first OptiPrep gradient where all of the protein in each fraction is loaded on the gel. In untreated cells, the majority of the receptor migrated in the light membrane fractions (fractions 1-7) used to purify and concentrate caveolae (Control). Filipin treatment caused the receptor distribution to shift toward the bottom of this gradient (Filipin) into fractions containing the bulk of the membrane proteins (see Fig. 1 ). Previously, we showed that immunogold labeling detected clustered receptors in PMA-treated cells (29) . In contrast to filipin, PMA treatment did not reduce the number of folate receptors (PMA) in the caveolae fraction. Therefore, two different assays (immunoblotting and folic acid binding) detected filipin-induced movement of folate receptors from the caveolae fraction to fractions containing the bulk of the plasma membrane.
Both functional folate receptors (22) and a caveolae internalization cycle (29) appear to be required for the uptake of physiologic concentrations of 5-methyltetrahydrofolate. An essential function for clustered receptors has not been determined. The ability of filipin to uncluster the folate receptor provided a potential tool for assessing this requirement (Fig. 4) . Cells were either not treated (Control) or incubated in the presence of filipin (Filipin) before
measuring [3H]folic acid internalization. Ordinarily, the ratio of internal to external bound [3H]folic acid in MA104 cells is H I (Control). In filipin-treated cells, however, this
ratio was reduced by ~50%. A similar inhibition of receptor internalization was seen in cells exposed to PMA (PMA), a drug that prevents caveolae internalization without unclustering receptors (PMA; Fig. 3 ).
Another activity of cholesterol-binding drugs is to disassemble the caveolae coat (25) . A more specific tool for unclustering GPI-anchored receptors may be anti-receptor mAbs. Jemmerson and Agree (9) showed that the choice of mAb used to localize GPI-anchored alkaline phosphatase affects the localization of the protein. Some antibodies give a dispersed distribution, while others give a clustered pattern. Mayor et al. (18) reported that cells incubated in the presence of mAb anti-folate receptor Figure 3 . Filipin shifts the folate receptor from caveolae to the bulk membrane fractions. MA104 cells were either not treated (Control), incubated for 15 rain in the presence of 10 Ixg/ml filipin (Filipin), or incubated in the presence of 1 ~M P M A for 1 h at 37°C. At the end of the treatment, plasma membranes were purified and processed for OptiPrep 1 gradients according to standard methods. The total protein from each fraction was loaded on gels and immunoblotted using mAb anti-folate receptor Mov19. 
(Movl8).
To see how Movl9 affected the distribution of bound [3H]folic acid, MA104 cells were incubated for 1 h at 37°C in the presence or absence of Movl9 before adding [3H]folic acid to the dish for an additional 1 h (Fig. 5 B) . Caveolae were isolated and the amount of bound [3H]folic acid was measured. Untreated cells (Control) had a specific binding of ~150 pmol/mg of protein in the caveolae fraction, while Movl9-treated cells had only ~75 pmol/mg of protein (Mov19) in this fraction. The antibody had no effect on the distribution of caveolin or the total protein content of the fractions (data not shown). As was observed for filipin treatment (Table II) , the [3H]folic acid lost from the caveolae fraction was shifted to the noncaveolae fraction (Table III) . If the cells were incubated sequentially with Movl9 and anti-mouse IgG (Mov19 + 2°Ab), the specific binding of [3H]folic acid in the caveolae fraction returned to control values. The anti-mouse IgG alone had no effect (2°Ab), and neither did Movl8 (Mov18). (Fig.  6 A) . Cells were incubated in the presence of either Mov19 (Fig. 6 B) . After a 3-h incubation in the presence ( I ) or absence ([]) of the mAb, control cells had taken up ~2 pmol/mg of protein, while cells exposed to Movl9 only accumulated 0.4 pmol/mg. PMA inhibited uptake to the same extent (©).
Movl9 also inhibited [3H]folic acid internalization
(Mov19), Movl9 + anti-mouse IgG (Mov19 + 2°Ab),
Folate Delivery to Cytoplasm by Caveolae
Biochemical (11) and morphologic (24) studies have failed to detect folate receptors in endosomes of MA104 cells. Previously, we used Percoll fractionation to show that 5-[3H]methyltetrahydrofolate moves directly from the plasma membrane to the cytosol of the cell, and the blockage of this step by monensin (11) . To be sure we could detect movement of a ligand to internal membranes with this procedure, we tested 125I-transferrin. MA104 cells were incubated in the presence of 125I-transferrin for 1 h at 4°C, and one set was assayed immediately while the other was warmed to 37°C for 0.5 h (Fig. 7) . Initially, most of the cellassociated radioactivity was found in the plasma mem- We used 125I-transferrin and 5-[3H]methyltetrahydrofolate to identify inhibitors that might distinguish between the two internalization pathways. In MA104 cells, uptake of 5-methyltetrahydrofolate is inhibited by PMA (29) . Kapfan et al. (14) showed that transferrin internalization is inhibited by phenylarsine oxide (PAO). Cells were incubated in the presence of 0.32 ~g/ml of 125I-transferrin for various times at 37°C before total cell membranes (plasma membrane and internal membranes) were separated from cytosol (Fig. 8 A) . There was an immediate increase in 1251-transferrin associated with the membrane fraction that reached a plateau after 1 h of incubation ([]). We did not detect a significant amount of radiolabel in the cytosol during the incubation (11) . Cells that were exposed to PAO during the incubation with ~25I-transferrin had 50% less radiolabel associated with the membrane fraction (A), indicating that receptor internalization and recycling was blocked. Replacing the PAO with PMA caused a slight increase in membrane-associated radioactivity (©). While PAO inhibited the uptake of ~25I-transferrin, it had no effect on the internalization of 5-[3H]methyltetrahydrofolate (Fig. 8 B) . Neither the internalization of membrane-bound vitamin (compare ~ with ©) nor the delivery to the cytoplasm (compare • with • on the ordinate) was affected by PAO. 
Discussion
One of the unresolved questions about potocytosis has been the exact route the receptor takes during the internalization cycle. We have used cell fractionation to better understand this pathway. A method for isolating caveolae was used that previously has been shown, by both immunoblotting (17, 20, 32) and PAGE (32) , to yield a unique Cells were processed to isolate cytosol, plasma membrane, and internal membranes from Percoll gradients as described. The amount of 125I-transferrin in each of these fractions was then measured. All values are the average of four trials _+SD. population of membranes. While no membrane purification procedure could ever yield an absolutely pure preparation of caveolae, the results we obtained with this method are consistent with previous biochemical (11) and morphologic (24) studies that localized the cycle to caveolae membrane in MA104 cells. We were able to recover :,-65% of the bound folate in the caveolae fraction and detect both internal and external populations of receptor. Since all receptors appear to be functional in these cells (11) , the 35% associated with noncaveolae membrane must be able to move into caveolae before internalization. Neither the folate receptor nor 5-methyltetrahydrofolate was found in endosomes during receptor recycling even though 125I-transferrin movement to this compartment was easily detected. Furthermore, inhibitors that interfere with the clathrin-coated pit pathway did not affect the internalization of folate. These results affirm (4) that potocytosis is a distinct endocytic pathway.
Ligand-binding studies detect opened and closed caveolae compartments, but electron microscopic immunogold labeling cannot distinguish between the two. Furthermore, immunoelectron microscopy failed to find folate receptors associated with endosomes in these cells (24) . In the current study, caveolae with sequestered receptors (closed) and caveolae with receptors accessible at the cell surface (open) were in the same caveolae fraction (Fig. 2) . Therefore, either the closed caveolae that internalize folate never detach from the plasma membrane or they become plasmalemmal vesicles with the same density as caveolae membrane and, as a consequence, migrate identically on the gradients. Treatment of cells with PMA stimulates the disappearance of invaginated caveolae and the return of internalized receptors to the cell surface (29) . Yet, by cell fractionation, the caveolae membrane in these cells is indistinguishable from caveolae in untreated cells (Fig. 3) . This means caveolae membrane must have physical characteristics that are independent of membrane shape. The flask-shaped membrane originally designated as caveolae (34) may correspond to the subset of caveolae membrane captured by the fixation process during internalization. The remaining caveolae, which have the same lipid and protein composition, cannot be distinguished in thin-section images from other segments of membrane. This conclusion is supported by rapid-freeze, deep-etch images of fibroblast membranes showing many uninvaginated caveolae decorated with a caveolar coat (25) . Caveolae membrane may constitute a much larger percentage of the plasma membrane than thin-section morphology indicates. Filipin caused an ~50% decline in number of folate receptors in the caveolae fraction (Fig. 3) . After this treatment, approximately two-thirds of the receptors were in the bulk membrane fraction. This suggests that the drug does not completely uncluster folate receptors. Immunofluorescence images also indicate filipin only partially unclusters the receptor in fixed cells (see Fig. 1) (23) . Furthermore, we were forced to use a lower concentration of the drug in the current study to keep the cells alive. Therefore, the biochemical and the immunofluorescence results agree.
Clustered folate receptors appear to be required for the efficient internalization of folate (Figs. 4, 5 B, and 6, A and  B) . Two different treatments that partially unclustered the receptor inhibited the potocytosis of 5-[3H]methyltetrahydrofolate by decreasing the internalization of receptors. Receptor clustering has also been found to be required for receptor-mediated endocytosis by clathrincoated pits (2) . The percentage of folate receptors clustered in caveolae (65%) is nearly the same as the portion of low density lipoprotein receptors (50-70%) found in coated pits (3) . Thus, the aggregation of receptors over a membrane domain specialized for internalization appears to be a common mechanism for guaranteeing efficient uptake of a ligand. The mechanism of folate receptor clustering, however, is distinctly different than for the low density lipoprotein receptor. The targeting of receptors to clathrin-coated pits depends on protein-protein interactions between a specific amino acid sequence in the cytoplasmic tail and clathrin-associated coat proteins (8) . The clustering of GPI-anchored proteins in caveolae, by contrast, appears to depend on lipid-lipid interactions (23, 27) . The lipid anchor may convey high mobility on GPI proteins when they are in noncaveolae membrane and low mobility in glycolipid/cholesterol-rich caveolae. As a consequence, the GPI protein spends more time in caveolae and, at the steady state, is predominantly clustered.
A dynamic GPI-anchored protein, shuttling between caveolae and noncaveolae membrane, would explain the unexpected effect of Movl9. Previous morphologic studies (18) , together with the current biochemical experiments (Fig. 5 A) , indicate that after this anti-folate receptor mAb binds, the receptors are partially dispersed in the plane of the membrane. The morphologic (18) and fractionation experiments (Fig. 5 A) also agree that when the cells are incubated in the presence of both the mAb and an antimouse IgG, the receptors are clustered in caveolae. Cell fractionation (Fig. 5 A) further shows that receptors from untreated cells are clustered in caveolae, which agrees with the recent observation that GPI proteins inserted into the plasma membrane of lymphocytes spontaneously cluster (33) . Therefore, the Mov19 must alter the normal, clustered pattern of the folate receptor. The mAb could do this in two ways: (a) it may bind to receptors migrating in noncaveolae membrane and prevent their return to caveolae. (b) Alternatively, the mAb might bind to clustered receptors and cause them to disperse in the plane of the membrane. Regardless of the actual mechanism, not all mAbs against GPI proteins seem to uncluster (Fig. 5 A) (9) .
The effect of the mAb anti-folate receptor on receptor
